Higher Fracture Risk Not Seen With SGLT2 Inhibitors

Increased fracture risk seen in short-term studies may have been due to hypovolemia or osmotic diuresis, resulting in falls, rather than an effect on bone.

Related Keywords

United States ,Canada ,Netherlands ,Vancouver ,British Columbia ,Maastricht ,Limburg ,American ,Veerle Van Hulten ,Van Hulten ,Sarah Berry ,Drug Administration ,Maastricht University ,Society For Bone ,Marcus Institute For Aging Research ,Mineral Research ,Harvard Medical School ,Marcus Institute ,Aging Research ,Fractures ,Sglt2 Inhibitors ,Odium Glucose Transporter 2 Inhibitors ,Odium Glucose Co Transporter 2 Inhibitors ,Sodium Glucose Cotransporter 2 Inhibitors ,Diabetes Mellitus Type 2 ,Iabetes Mellitus Type Ii ,Type 2 Diabetes ,Elderly Concerns Of Older Adults ,Geriatrics Elder Care ,Osteoporosis ,Bones ,Dpp 4 Inhibitors ,Dipeptidyl Peptidase 4 Inhibitors ,Minerals ,Calcium , ,Dizziness ,Fatigue ,Metabolism ,